[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 4963 followers Created: 2025-07-20 21:10:49 UTC 🦉 Among those with metabolic liver disease and diabetes, GLP-1 agonists reduced cirrhosis, its complications, and mortality versus DPP-4 inhibitors. Alcohol-related liver risk may be mitigated. #GLP1 #diabetes $NVO $LLY $AZN $SNY $VKTX $GSK $PFE $RHHBY XXX engagements  **Related Topics** [pfe](/topic/pfe) [manat](/topic/manat) [$rhhby](/topic/$rhhby) [$gsk](/topic/$gsk) [$sny](/topic/$sny) [$lly](/topic/$lly) [$nvo](/topic/$nvo) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/AponiaAnalytics/status/1947041529182199943)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
aponia_analytics @AponiaAnalytics on x 4963 followers
Created: 2025-07-20 21:10:49 UTC
🦉 Among those with metabolic liver disease and diabetes, GLP-1 agonists reduced cirrhosis, its complications, and mortality versus DPP-4 inhibitors. Alcohol-related liver risk may be mitigated.
#GLP1 #diabetes $NVO $LLY $AZN $SNY $VKTX $GSK $PFE $RHHBY
XXX engagements
Related Topics pfe manat $rhhby $gsk $sny $lly $nvo stocks healthcare
/post/tweet::1947041529182199943